Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin vs Oxybutynin in Overactive Bladder
NCT01423838Phase 4Unknown
- Sponsor
- Adana Numune Training and Research Hospital
- Start
- Sep 2011
- Primary completion
- Sep 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of solifenacin in overactive bladder (OAB), sponsored by Adana Numune Training and Research Hospital. Status: unknown.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT01423838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01423838.